» Articles » PMID: 12776174

Runx3 Knockouts and Stomach Cancer

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2003 May 31
PMID 12776174
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Gene targeting often results in knockout mice that show several phenotypes, some of which may not directly relate to the intrinsic function of the disrupted gene. Hence, to study the biological function of genes using knockout mice, one must identify the defects that are directly due to the loss of the targeted gene. Runx3 is a transcription factor that regulates lineage-specific gene expression in developmental processes. Recently, two groups produced Runx3 knockout mice. Two comparable defects were identified in both knockout strains, one involved neurogenesis and the other thymopoiesis. In addition, a stomach defect pertaining to gastric cancer was observed in one of the mutant strains, but not in the other. Here, we assess the differences between the two Runx3 mutant strains and discuss further studies that could reconcile these discrepancies. This article highlights the difficulties of inferring gene function through the interpretation of knockout phenotypes.

Citing Articles

Methylation of Promoter 2 in the Whole Blood of Children with Ulcerative Colitis.

Dybska E, Nowak J, Banaszkiewicz A, Szaflarska-Poplawska A, Kierkus J, Kwiecien J Genes (Basel). 2022; 13(9).

PMID: 36140736 PMC: 9498668. DOI: 10.3390/genes13091568.


Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer.

Chen X, Deng Y, Shi Y, Zhu W, Cai Y, Xu C Oncol Lett. 2018; 15(4):5043-5055.

PMID: 29545901 PMC: 5840764. DOI: 10.3892/ol.2018.7993.


Epigenetic inactivation of in colorectal cancer.

Shin E, Kim H, Son M, Ahn T, Lee H, Lim D Ann Surg Treat Res. 2018; 94(1):19-25.

PMID: 29333422 PMC: 5765274. DOI: 10.4174/astr.2018.94.1.19.


The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis.

Song X, Li B, Zhou E, Wu F Onco Targets Ther. 2016; 9:5339-47.

PMID: 27616890 PMC: 5008647. DOI: 10.2147/OTT.S77828.


Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.

Xu L, Lan H, Su Y, Li J, Wan J Drug Des Devel Ther. 2015; 9:2855-65.

PMID: 26082616 PMC: 4461130. DOI: 10.2147/DDDT.S76358.


References
1.
Levanon D, Bernstein Y, NEGREANU V, Ghozi M, Bar-Am I, Aloya R . A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 1996; 15(3):175-85. DOI: 10.1089/dna.1996.15.175. View

2.
Ghozi M, Bernstein Y, NEGREANU V, Levanon D, Groner Y . Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci U S A. 1996; 93(5):1935-40. PMC: 39886. DOI: 10.1073/pnas.93.5.1935. View

3.
Otto F, Thornell A, Crompton T, Denzel A, Gilmour K, Rosewell I . Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89(5):765-71. DOI: 10.1016/s0092-8674(00)80259-7. View

4.
Geoffroy V, Corral D, Zhou L, Lee B, Karsenty G . Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm Genome. 1998; 9(1):54-7. DOI: 10.1007/s003359900679. View

5.
Wang T, Goldenring J, Dangler C, Ito S, Mueller A, Jeon W . Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 1998; 114(4):675-89. DOI: 10.1016/s0016-5085(98)70581-5. View